Creative Planning »

Summit Therapeutics shares owned by Creative Planning

Quarter-by-quarter ownership of Summit Therapeutics (SMMT) shares owned by Creative Planning from 13F filings

Historical chart of Creative Planning investment in Summit Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Summit Therapeutics held by Creative Planning consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Summit Therapeutics by Creative Planning

Quarter filed Position value Share count Share price at filing
2024-12-31 $339k 19k 17.85
2024-09-30 $342k 16k 21.90
2024-06-30 $84k 11k 7.80
2023-06-30 $41k 16k 2.51
2023-03-31 $22k 13k 1.75

More positions owned by Creative Planning

Ishares Tr Core S&p500 Etf (IVV)
Vanguard Bd Index Fds Total Bnd Mrkt (BND)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Spdr Ser Tr Portfolio S&p400 (SPMD)
Ishares Core Msci Emkt (IEMG)
Vanguard Index Fds Large Cap Etf (VV)
Apple (AAPL)
Spdr Index Shs Fds Portfolio Devlpd (SPDW)
Vanguard Index Fds Mid Cap Etf (VO)
Spdr Ser Tr Portfolio S&p500 (SPLG)
Vanguard Scottsdale Fds Int-term Corp (VCIT)
Vanguard Index Fds Total Stk Mkt (VTI)
Schwab Strategic Tr Us Lrg Cap Etf (SCHX)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Tr National Mun Etf (MUB)

View all positions for Creative Planning

Top funds holding Summit Therapeutics

Baker Bros. Advisors
Vanguard Group
BlackRock
FMR
T. Rowe Price Associates
State Street Corporation
Geode Capital Management
Millennium Management
Twin Tree Management
Charles Schwab Investment Management
Standard Life Aberdeen
UBS Group
Rock Springs Capital Management
Jane Street
Goldman Sachs Group

View all funds holding Summit Therapeutics